Glycopeptide Antibiotics Market - Global Outlook and Forecast 2023-2027

Report ID: 697478 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Glycopeptide Antibiotics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Glycopeptide Antibiotics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Glycopeptide Antibiotics Overall Market Size
    2.1 Global Glycopeptide Antibiotics Market Size: 2021 VS 2027
    2.2 Global Glycopeptide Antibiotics Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Glycopeptide Antibiotics Players in Global Market
    3.2 Top Global Glycopeptide Antibiotics Companies Ranked by Revenue
    3.3 Global Glycopeptide Antibiotics Revenue by Companies
    3.4 Top 3 and Top 5 Glycopeptide Antibiotics Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Glycopeptide Antibiotics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Glycopeptide Antibiotics Players in Global Market
        3.6.1 List of Global Tier 1 Glycopeptide Antibiotics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Glycopeptide Antibiotics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Glycopeptide Antibiotics Market Size Markets, 2021 & 2027
        4.1.2 Vancomycin
        4.1.3 Teicoplanin
        4.1.4 Bleomycin
    4.2 By Type - Global Glycopeptide Antibiotics Revenue & Forecasts
        4.2.1 By Type - Global Glycopeptide Antibiotics Revenue, 2016-2021
        4.2.2 By Type - Global Glycopeptide Antibiotics Revenue, 2022-2027
        4.2.3 By Type - Global Glycopeptide Antibiotics Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Glycopeptide Antibiotics Market Size, 2021 & 2027
        5.1.2 Enterococcus Treatment
        5.1.3 Staphylococcus Aureus Treatment
    5.2 By Application - Global Glycopeptide Antibiotics Revenue & Forecasts
        5.2.1 By Application - Global Glycopeptide Antibiotics Revenue, 2016-2021
        5.2.2 By Application - Global Glycopeptide Antibiotics Revenue, 2022-2027
        5.2.3 By Application - Global Glycopeptide Antibiotics Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Glycopeptide Antibiotics Market Size, 2021 & 2027
    6.2 By Region - Global Glycopeptide Antibiotics Revenue & Forecasts
        6.2.1 By Region - Global Glycopeptide Antibiotics Revenue, 2016-2021
        6.2.2 By Region - Global Glycopeptide Antibiotics Revenue, 2022-2027
        6.2.3 By Region - Global Glycopeptide Antibiotics Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Glycopeptide Antibiotics Revenue, 2016-2027
        6.3.2 US Glycopeptide Antibiotics Market Size, 2016-2027
        6.3.3 Canada Glycopeptide Antibiotics Market Size, 2016-2027
        6.3.4 Mexico Glycopeptide Antibiotics Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Glycopeptide Antibiotics Revenue, 2016-2027
        6.4.2 Germany Glycopeptide Antibiotics Market Size, 2016-2027
        6.4.3 France Glycopeptide Antibiotics Market Size, 2016-2027
        6.4.4 U.K. Glycopeptide Antibiotics Market Size, 2016-2027
        6.4.5 Italy Glycopeptide Antibiotics Market Size, 2016-2027
        6.4.6 Russia Glycopeptide Antibiotics Market Size, 2016-2027
        6.4.7 Nordic Countries Glycopeptide Antibiotics Market Size, 2016-2027
        6.4.8 Benelux Glycopeptide Antibiotics Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Glycopeptide Antibiotics Revenue, 2016-2027
        6.5.2 China Glycopeptide Antibiotics Market Size, 2016-2027
        6.5.3 Japan Glycopeptide Antibiotics Market Size, 2016-2027
        6.5.4 South Korea Glycopeptide Antibiotics Market Size, 2016-2027
        6.5.5 Southeast Asia Glycopeptide Antibiotics Market Size, 2016-2027
        6.5.6 India Glycopeptide Antibiotics Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Glycopeptide Antibiotics Revenue, 2016-2027
        6.6.2 Brazil Glycopeptide Antibiotics Market Size, 2016-2027
        6.6.3 Argentina Glycopeptide Antibiotics Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Glycopeptide Antibiotics Revenue, 2016-2027
        6.7.2 Turkey Glycopeptide Antibiotics Market Size, 2016-2027
        6.7.3 Israel Glycopeptide Antibiotics Market Size, 2016-2027
        6.7.4 Saudi Arabia Glycopeptide Antibiotics Market Size, 2016-2027
        6.7.5 UAE Glycopeptide Antibiotics Market Size, 2016-2027
7 Players Profiles
    7.1 ANI Pharmaceuticals
        7.1.1 ANI Pharmaceuticals Corporate Summary
        7.1.2 ANI Pharmaceuticals Business Overview
        7.1.3 ANI Pharmaceuticals Glycopeptide Antibiotics Major Product Offerings
        7.1.4 ANI Pharmaceuticals Glycopeptide Antibiotics Revenue in Global (2016-2021)
        7.1.5 ANI Pharmaceuticals Key News
    7.2 Hikma Pharmaceuticals plc
        7.2.1 Hikma Pharmaceuticals plc Corporate Summary
        7.2.2 Hikma Pharmaceuticals plc Business Overview
        7.2.3 Hikma Pharmaceuticals plc Glycopeptide Antibiotics Major Product Offerings
        7.2.4 Hikma Pharmaceuticals plc Glycopeptide Antibiotics Revenue in Global (2016-2021)
        7.2.5 Hikma Pharmaceuticals plc Key News
    7.3 Aurobindo Pharma
        7.3.1 Aurobindo Pharma Corporate Summary
        7.3.2 Aurobindo Pharma Business Overview
        7.3.3 Aurobindo Pharma Glycopeptide Antibiotics Major Product Offerings
        7.3.4 Aurobindo Pharma Glycopeptide Antibiotics Revenue in Global (2016-2021)
        7.3.5 Aurobindo Pharma Key News
    7.4 Allergan
        7.4.1 Allergan Corporate Summary
        7.4.2 Allergan Business Overview
        7.4.3 Allergan Glycopeptide Antibiotics Major Product Offerings
        7.4.4 Allergan Glycopeptide Antibiotics Revenue in Global (2016-2021)
        7.4.5 Allergan Key News
    7.5 Theravance Biopharma
        7.5.1 Theravance Biopharma Corporate Summary
        7.5.2 Theravance Biopharma Business Overview
        7.5.3 Theravance Biopharma Glycopeptide Antibiotics Major Product Offerings
        7.5.4 Theravance Biopharma Glycopeptide Antibiotics Revenue in Global (2016-2021)
        7.5.5 Theravance Biopharma Key News
    7.6 Shenwei Pharmaceutical
        7.6.1 Shenwei Pharmaceutical Corporate Summary
        7.6.2 Shenwei Pharmaceutical Business Overview
        7.6.3 Shenwei Pharmaceutical Glycopeptide Antibiotics Major Product Offerings
        7.6.4 Shenwei Pharmaceutical Glycopeptide Antibiotics Revenue in Global (2016-2021)
        7.6.5 Shenwei Pharmaceutical Key News
    7.7 Zhejiang Hisun Pharmaceutical Co., Ltd.
        7.7.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Corporate Summary
        7.7.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
        7.7.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Major Product Offerings
        7.4.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Revenue in Global (2016-2021)
        7.7.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Key News
    7.8 Lytix Biopharma
        7.8.1 Lytix Biopharma Corporate Summary
        7.8.2 Lytix Biopharma Business Overview
        7.8.3 Lytix Biopharma Glycopeptide Antibiotics Major Product Offerings
        7.8.4 Lytix Biopharma Glycopeptide Antibiotics Revenue in Global (2016-2021)
        7.8.5 Lytix Biopharma Key News
    7.9 Alvogen
        7.9.1 Alvogen Corporate Summary
        7.9.2 Alvogen Business Overview
        7.9.3 Alvogen Glycopeptide Antibiotics Major Product Offerings
        7.9.4 Alvogen Glycopeptide Antibiotics Revenue in Global (2016-2021)
        7.9.5 Alvogen Key News
    7.10 Eli Lilly and Company
        7.10.1 Eli Lilly and Company Corporate Summary
        7.10.2 Eli Lilly and Company Business Overview
        7.10.3 Eli Lilly and Company Glycopeptide Antibiotics Major Product Offerings
        7.10.4 Eli Lilly and Company Glycopeptide Antibiotics Revenue in Global (2016-2021)
        7.10.5 Eli Lilly and Company Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Glycopeptide Antibiotics Market Opportunities & Trends in Global Market
    Table 2. Glycopeptide Antibiotics Market Drivers in Global Market
    Table 3. Glycopeptide Antibiotics Market Restraints in Global Market
    Table 4. Key Players of Glycopeptide Antibiotics in Global Market
    Table 5. Top Glycopeptide Antibiotics Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global Glycopeptide Antibiotics Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global Glycopeptide Antibiotics Revenue Share by Companies, 2016-2021
    Table 8. Global Companies Glycopeptide Antibiotics Product Type
    Table 9. List of Global Tier 1 Glycopeptide Antibiotics Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Glycopeptide Antibiotics Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Glycopeptide Antibiotics Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Glycopeptide Antibiotics Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - Glycopeptide Antibiotics Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global Glycopeptide Antibiotics Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - Glycopeptide Antibiotics Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - Glycopeptide Antibiotics Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global Glycopeptide Antibiotics Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global Glycopeptide Antibiotics Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global Glycopeptide Antibiotics Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America Glycopeptide Antibiotics Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe Glycopeptide Antibiotics Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia Glycopeptide Antibiotics Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America Glycopeptide Antibiotics Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa Glycopeptide Antibiotics Revenue, (US$, Mn), 2022-2027
    Table 30. ANI Pharmaceuticals Corporate Summary
    Table 31. ANI Pharmaceuticals Glycopeptide Antibiotics Product Offerings
    Table 32. ANI Pharmaceuticals Glycopeptide Antibiotics Revenue (US$, Mn), (2016-2021)
    Table 33. Hikma Pharmaceuticals plc Corporate Summary
    Table 34. Hikma Pharmaceuticals plc Glycopeptide Antibiotics Product Offerings
    Table 35. Hikma Pharmaceuticals plc Glycopeptide Antibiotics Revenue (US$, Mn), (2016-2021)
    Table 36. Aurobindo Pharma Corporate Summary
    Table 37. Aurobindo Pharma Glycopeptide Antibiotics Product Offerings
    Table 38. Aurobindo Pharma Glycopeptide Antibiotics Revenue (US$, Mn), (2016-2021)
    Table 39. Allergan Corporate Summary
    Table 40. Allergan Glycopeptide Antibiotics Product Offerings
    Table 41. Allergan Glycopeptide Antibiotics Revenue (US$, Mn), (2016-2021)
    Table 42. Theravance Biopharma Corporate Summary
    Table 43. Theravance Biopharma Glycopeptide Antibiotics Product Offerings
    Table 44. Theravance Biopharma Glycopeptide Antibiotics Revenue (US$, Mn), (2016-2021)
    Table 45. Shenwei Pharmaceutical Corporate Summary
    Table 46. Shenwei Pharmaceutical Glycopeptide Antibiotics Product Offerings
    Table 47. Shenwei Pharmaceutical Glycopeptide Antibiotics Revenue (US$, Mn), (2016-2021)
    Table 48. Zhejiang Hisun Pharmaceutical Co., Ltd. Corporate Summary
    Table 49. Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Product Offerings
    Table 50. Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Revenue (US$, Mn), (2016-2021)
    Table 51. Lytix Biopharma Corporate Summary
    Table 52. Lytix Biopharma Glycopeptide Antibiotics Product Offerings
    Table 53. Lytix Biopharma Glycopeptide Antibiotics Revenue (US$, Mn), (2016-2021)
    Table 54. Alvogen Corporate Summary
    Table 55. Alvogen Glycopeptide Antibiotics Product Offerings
    Table 56. Alvogen Glycopeptide Antibiotics Revenue (US$, Mn), (2016-2021)
    Table 57. Eli Lilly and Company Corporate Summary
    Table 58. Eli Lilly and Company Glycopeptide Antibiotics Product Offerings
    Table 59. Eli Lilly and Company Glycopeptide Antibiotics Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. Glycopeptide Antibiotics Segment by Type
    Figure 2. Glycopeptide Antibiotics Segment by Application
    Figure 3. Global Glycopeptide Antibiotics Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Glycopeptide Antibiotics Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Glycopeptide Antibiotics Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Glycopeptide Antibiotics Revenue in 2020
    Figure 8. By Type - Global Glycopeptide Antibiotics Revenue Market Share, 2016-2027
    Figure 9. By Application - Global Glycopeptide Antibiotics Revenue Market Share, 2016-2027
    Figure 10. By Region - Global Glycopeptide Antibiotics Revenue Market Share, 2016-2027
    Figure 11. By Country - North America Glycopeptide Antibiotics Revenue Market Share, 2016-2027
    Figure 12. US Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe Glycopeptide Antibiotics Revenue Market Share, 2016-2027
    Figure 16. Germany Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 17. France Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia Glycopeptide Antibiotics Revenue Market Share, 2016-2027
    Figure 24. China Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 28. India Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America Glycopeptide Antibiotics Revenue Market Share, 2016-2027
    Figure 30. Brazil Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa Glycopeptide Antibiotics Revenue Market Share, 2016-2027
    Figure 33. Turkey Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE Glycopeptide Antibiotics Revenue, (US$, Mn), 2016-2027
    Figure 37. ANI Pharmaceuticals Glycopeptide Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Hikma Pharmaceuticals plc Glycopeptide Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Aurobindo Pharma Glycopeptide Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. Allergan Glycopeptide Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. Theravance Biopharma Glycopeptide Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Shenwei Pharmaceutical Glycopeptide Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 44. Lytix Biopharma Glycopeptide Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 45. Alvogen Glycopeptide Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 46. Eli Lilly and Company Glycopeptide Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Glycopeptide Antibiotics Market In Pharma & Healthcare report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Glycopeptide Antibiotics Market In Pharma & Healthcare report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Glycopeptide Antibiotics Market In Pharma & Healthcare report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports